A rationally-designed library of ternary siRNA polyplexes was developed and screened for gene silencing efficacy in vitro and in vivo with the goal of overcoming both cell-level and systemic delivery barriers. [2-(dimethylamino) ethyl methacrylate] (DMAEMA) was homopolymerized or copolymerized (50 mol% each) with butyl methacrylate (BMA) from a reversible addition -fragmentation chain transfer (RAFT) chain transfer agent, with and without pre-conjugation to polyethylene glycol (PEG). Both single block polymers were tested as core-forming units, and both PEGylated, diblock polymers were screened as corona-forming units. Ternary siRNA polyplexes were assembled with varied amounts and ratios of core-forming polymers to PEGylated corona-forming polymers. The impact of polymer composition/ratio, hydrophobe (BMA) placement, and surface PEGylation density was correlated to important outcomes such as polyplex size, stability, pH-dependent membrane disruptive activity, biocompatibility, and gene silencing efficiency. The lead formulation, DB4-PDB12, was optimally PEGylated not only to ensure colloidal stability (no change in size by DLS between 0 and 24 h) and neutral surface charge (0.139 mV) but also to maintain higher cell uptake (> 90% positive cells) than the most densely PEGylated particles. The DB4-PDB12 polyplexes also incorporated BMA in both the polyplex core-and corona-forming polymers, resulting in robust endosomolysis and in vitro siRNA silencing (~85% protein level knockdown) of the model gene luciferase across multiple cell types. Further, the DB4-PDB12 polyplexes exhibited greater stability, increased blood circulation time, reduced renal clearance, increased tumor biodistribution, and greater silencing of luciferase compared to our previously-optimized, binary parent formulation following intravenous (i.v.) delivery. This polyplex library approach enabled concomitant optimization of the composition and ratio of core-and corona-forming polymers (indirectly tuning PEGylation density) and identification of a ternary nanomedicine optimized to overcome important siRNA delivery barriers in vitro and in vivo.
Introduction
RNA interference (RNAi) was initially observed by Mello and Fire et al. almost twenty years ago [1] , yet cellular and systemic delivery barriers have continued to limit the clinical application of siRNA [2] . Naked siRNAs do not readily enter cells, have no inherent mechanism for endosome escape, and are rapidly cleared through filtration in the kidneys after systemic administration [3, 4] . Thus, the use of siRNA as a safe and efficacious therapeutic is contingent upon its effective delivery to the desired tissue, cell type, and sub-cellular compartment of interest. To date, a variety of methodologies have been developed to overcome the challenge of siRNA delivery, including covalent modifications [5, 6] , antibody-protamine fusion [7] , liposomal encapsulation [8] , and nanoparticle formulations of cationic lipids or polymers [9] [10] [11] .
Packaging of siRNA into cationic polymer-or lipid-based nanoparticles is one of the most investigated approaches [12, 13] . By this approach, siRNA is packaged onto nanocarriers with an excess of cationic charge which serves to drive cellular uptake through interaction with the anionic cellular membrane [14] . Moreover, surface PEGylation has been widely employed as a strategy to neutralize the surface charge of siRNA nanocarriers to reduce opsonization and increase stealth from the mononuclear phagocyte system (MPS) following systemic administration [15] [16] [17] . However, polyplexes formulated from diblock polymers comprising PEG and a purely cationic polymer block suffer from a lack of stability in vivo [11, [18] [19] [20] . This class of polyplexes, formed solely through electrostatic interactions, is disassembled at the glomerular basement membrane (GBM) and cleared primarily through the kidneys, resulting in modest increases of circulation time over naked siRNA [21, 22] . In previous work, we endeavored to improve the performance of PEGylated cationic polyplexes through incorporation of hydrophobicity into the core of the polyplex to create siRNA nanocarriers stabilized by a combination of both electrostatic and hydrophobic interactions [23, 24] . This approach improved resilience against destabilization by polyanions such as the herapan sulfates found in the GBM, extended in vivo circulation times, enhanced intracellular delivery of siRNA due to pH-dependent membrane disruptive function tuned to the endolysosomal environment, and improved in vivo bioactivity in the liver, kidneys, and spleen.
Efforts to develop effective siRNA transfection materials through combinatorial approaches have yielded potent reagents that rival viral constructs. For example, the laboratories of Green, Langer, Anderson, et al. have developed large libraries of poly(β-amino esters) (PBAEs) and lipid or lipid-like chemistries through combinatorial methods with great success. Green et al. initially developed a library of cationic PBAEs in which the lead reagents were able to achieve pDNA transfection comparable to adenoviruses [25] and have more recently developed libraries which yielded PBAE derivatives highly effective at delivering siRNA and pDNA to glioblastomas [26, 27] . Anderson, Langer, and others have used combinatorial synthesis methods to develop large libraries of cationic lipid and lipid-like nanoparticles, reporting the most potent in vivo siRNA knockdown in multiple animal models to date [9, [28] [29] [30] [31] . Recently, Siegwart and coworkers utilized combinatorial synthesis to build new chemical classes of biodegradable dendrimer and polymer constructs that were incorporated as the cationic component of lipid nanoparticles [32, 33] . This combinatorial approach allowed for the rapid screening and narrowing of a large chemical space which produced lead compounds highly effective for both siRNA and miRNA delivery in vivo.
Library-based screens, such as those highlighted above, used high throughput synthesis methods to screen different compositions of cationic lipids [9, 29, 30, 34, 35] or polymers [25, 26, [31] [32] [33] [36] [37] [38] . This approach has proven powerful in elucidation of siRNA carrier structurefunction relationships, especially for endpoints focused on in vitro activity and/or in vivo liver gene silencing. In these studies, the authors did not utilize a PEGylation component [25, 26, 36, 37] or used a simple amphiphile (i.e., (mPEG2000-carbamoyl)-1,2-di-O-tetradecyl-sn-glyceride (PEG-DMG) lipid) to sterically stabilize the surface of the resultant nanoparticles [9, 29, 30, [32] [33] [34] [35] 38] . Here, we sought to create a library for simultaneous investigation of the composition (cationic versus balanced hydrophobic/cationic) and the relative quantity of both coreand (PEG-containing) corona-forming polyplex components. Moreover, we chose to focus our analysis on polyplex characteristics that are important for overcoming systemic barriers (stability for long circulation and reduced renal clearance) in addition to cell-level barriers (uptake/endosomal escape) that drive in vitro activity, the outcome that most previous screens have focused on. This multiparametric approach [29] expands upon our previous findings showing the importance of hydrophobe incorporation into the core of PEG-stabilized cationic polyplexes [23, 24] and provides a systematic study of structurefunction relationships of this new class of ternary, PEGylated siRNA polyplexes.
In this study, poly (Fig. 1 ). This strategy affords surface charge neutral, siRNA core-loaded si-NPs stabilized by electrostatic and hydrophobic interactions with the ability to rapidly tune the polyplex core-corona composition and degree of surface PEGylation. Through this combinatorial ternary si-NP approach, we were able to systematically study important polyplex characteristics such as surface PEGylation density, size, stability, endosomolysis, biocompatibility, cell uptake, and target gene silencing.
Materials and methods
2.1. Polymer synthesis and characterization 2.1.1. Materials All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise specified. DMAEMA and BMA monomers were passed twice through a basic alumina gravity column prior to use in order to remove inhibitors. 2,2-Azobis(2-methylpropionitrile) (AIBN) was recrystallized twice from methanol. All cell culture reagents were purchased through Fischer Scientific unless otherwise specified. Cell culture media and reagents, including Dulbecco's modified eagle medium (DMEM), fetal bovine serum (FBS), PBS (−/−), PBS (+/+), Pen/Strep, and gentamycin were purchased through Life Technologies (Grand Island, NY, USA). For dynamic light scattering (DLS) experiments, dsDNA was used as a model for siRNA. DLS measurements confirmed that si-NPs formed with dsDNA and siRNA are the same size ( Supplementary Fig. S1 ). For all fluorescent measurements, fluorophore-labeled dsDNA was used a model of siRNA. A list of oligonucleotides is provided in the supplement (Table S1 ).
Synthesis of 4-cyano-4-(ethylsulfanylthiocarbonyl)sulfanylpentanoic acid (ECT) and poly(ethylene glycol)-ECT (PEG-ECT) macro-chain transfer agent (macro-CTA)
ECT, the RAFT CTA, was synthesized according to a previously reported procedure [39] . The terminal carboxylic acid of ECT was then conjugated to PEG [23] . Briefly, methoxy-PEG (2 mmol, 10 g, Mn = 5000 Da), ECT (4 mmol, 1.045 g), and Dimethylaminopyridine (DMAP, 0.08 mmol, 10 mg) were dissolved in dry DCM (50 mL), and dicyclohexylcarbodiimide (DCC, 4 mmol, 0.82 g) was added while stirring. The reaction mixture was stirred for 48 h at room temperature (RT). Precipitated cyclohexyl urea was removed by filtration (0.2 μM pore size). The DCM layer was concentrated and precipitated into diethyl ether twice. The precipitated PEG-ECT was washed thrice with diethyl ether and dried under vacuum. 1 H NMR (400 MHz Spectrometer, Bruker, CDCl 3 ) showed 94% ECT conjugation to PEG [23] .
Polymer synthesis
RAFT controlled polymerization was used to synthesize four polymers, either from ECT or the PEG-ECT macro-CTA. P(DMAEMA-co-BMA) (DB) and pDMAEMA (D) were synthesized from ECT (Fig. S2) . In both cases, the target degree of polymerization was 150, reaction volume was 3 mL (Dioxane), degassing was done for 30 min by nitrogen purge, and polymerizations proceeded at 70°C for 20 h using AIBN as an initiator at 5:1 (CTA:AIBN) molar ratio. Reactions were stopped by removing the flask from heat and opening the reaction to air. The reaction mixtures were transferred to dialysis tubing and dialyzed one day against methanol and subsequently one day against diH 2 O to remove unreacted monomers prior to lyophilization. PEG-b-pDMAEMA (PD) and PEG-b-p(BMA-co-DMAEMA) (PDB) were synthesized from the PEG-ECT macro-CTA (Fig. S2) . The target degrees of polymerization were both 150. Reaction volumes were 3 mL (Dioxane), and degassing was done for 30 min by nitrogen purge. The polymerizations proceeded at 70°C for 24 h, and AIBN was used as an initiator at 5:1 (macro-CTA:AIBN) molar ratio. Reactions were stopped by removing the flask from heat and opening the reaction to air. The resulting diblock copolymers were precipitated in a cold solution of pentane:diethyl ether (90:10). The isolated polymers were dried, re-dissolved in ethanol, dialyzed one day against diH 2 O and lyophilized to yield the final product.
Polymer characterization
Polymers were characterized for composition and molecular weight (Mn) by 1 
where nmol Pol is the nmol of binary core-forming polymer, nmol NA is the nmol of nucleic acid, N:P is the ratio of amines to phosphates, RU DMAEMA is the number of repeating units of DMAEMA within the polymer backbone, nmol Pol 2 is the nmol of ternary corona-forming polymer, nmol Pol 1 is the nmol of binary core-forming polymer, RU DMAEMA 1 is the number of repeating units of DMAEMA within the binary core-forming polymer backbone, and RU DMAEMA 2 is the number of repeating units of DMAEMA within the ternary coronaforming polymer. After formulation of both the core-and corona-forming polymers with the nucleic acid at pH 4, a 5-fold excess of pH 8.0 phosphate buffer (10 mM) was added to the samples before filtering through 0.45 μm pore syringe filters. The hydrodynamic diameter (D h ) and zeta potential (ζ) of the resulting ternary si-NPs were then measured at 0 and 24 h using DLS (Malvern Zetasizer Nano ZS, Malvern, UK). The naming scheme used for ternary si-NP formulations is as follows: 
In vitro assessment of ternary si-NPs

Characterization of pH-dependent membrane disruption by the hemolysis assay
The hemolysis assay was used to assess all ternary si-NP formulations for cytocompatibility and the potential to escape the endolysosomal pathway. Red blood cells (RBCs) were obtained from anonymous donors and isolated by a well-established protocol [40] . After isolation, RBCs were incubated with varying concentrations (5, 15, and 30 μg/mL total polymer concentration) of each ternary si-NP formulation at four pH's representative of extracellular and endolysosomal ranges (7.4, 6.8, 6.2, 5.6). After 1 h of incubation, intact RBCs and cellular debris were centrifuged out, and supernatants were removed. The supernatants were measured for absorbance at 451 nm (hemoglobin absorbance) and percent hemolysis was determined relative to 1% Triton-X100 detergent.
Cell culture
Human triple negative breast cancer cells (MDA-MB-231) were cultured in DMEM supplemented with 10% FBS and 50 μg/mL gentamicin. Mouse embryonic fibroblasts (NIH3T3), and mouse mesenchymal stem cells (MSCs) were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep. MDA-MB-231, NIH3T3, and MSC cells were transduced with lentivirus encoding firefly luciferase, Green Fluorescent Protein (GFP), and Blasticidin resistance, enabling the generation of stable luciferase expressing-MDA-MB-231 (L231), NIH3T3 (L3 T3), and MSC (LMSC) cell lines.
Cytocompatability of ternary si-NPs
Cytocompatability of all ternary si-NP formulations was evaluated by adding scrambled siRNA containing ternary si-NPs to L231 and L3T3 cells and measuring relative cell number based on cellular luminescence. L231 and L3T3 cells were seeded to 96-well black-walled plates at a density of 5000 cells/well and allowed to adhere overnight. Ternary si-NP formulations were then added to each well in full serum media (DMEM, 10% FBS, 50 μg/mL gentamicin/1% Pen/Strep) at a final siRNA concentration of 100 nM and incubated for 24 h. After 24 h, media was replaced with luciferin containing media (150 μg/mL), and luminescence signal was collected on a Lumina III IVIS system (Xenogen Corporation, Alameda, CA, USA). Cell viability was then calculated as the ratio of luminescence of siScrambled siRNA treated cells to non-treated cells.
Cell uptake of ternary si-NPs
Cell uptake was evaluated in both MDA-MB-231 and NIH3T3 cell types by flow cytometry. MDA-MB-231 and NIH3T3 cells were seeded into 24-well plates at a density of 30,000 cells/well and allowed to adhere overnight. Alexa488-labeled model siRNA was loaded into ternary si-NPs which were added to each well to give a final nucleic acid concentration of 100 nM. These treatments were incubated with cells in full serum media (DMEM, 10% FBS, 50 μg/mL gentamicin/1% Pen/Strep) for 24 h. After 24 h, media with treatments was removed, and cells were washed with PBS (−/−), trypsinized (0.25%), transferred to microcentrifuge tubes, and centrifuged at 420 g for 7 min to yield a cell pellet. Pellets were re-suspended in 0.4 mL PBS(−/−) with 0.04% trypan blue to quench extracellular fluorescence, and intracellular si-NP delivery was measured by FACS (FACSCalibur, BD Biosciences, Franklin Lakes, NJ, USA) at excitation wavelength of 488 nm and emission wavelength of 519 nm.
In vitro siRNA silencing by ternary si-NPs
The gene silencing profile of ternary si-NP formulations was screened within L3T3s, L231s, and LMSCs. Cells were initially seeded in black-walled, 96-well plates at a density of 2000 cells/well and allowed to adhere overnight. Cells were then treated for 24 h in fullserum media (DMEM, 10% FBS, 50 μg/mL gentamicin/1% Pen/Strep) with all ternary si-NP formulations prepared as described above and containing an anti-luciferase or scrambled siRNA sequence (100 nM). After 24 h, treatment media was replaced by luciferin containing media (150 μg/mL), and cellular luminescence was measured using an IVIS Lumina III imaging system (Xenogen Corporation, Alameda, CA, USA). The cells were then incubated for an additional 24 h after luciferincontaining media was replaced by low-serum media (DMEM, 1% FBS, 50 μg/mL gentamicin/1% Pen/Strep), which was used to minimize cellular overgrowth. Cellular luminescence was re-measured at 48 h and normalized to treatment with analogous formulations containing a scrambled control siRNA sequence in all cases.
2.4.
Comparative analysis of binary PDB and ternary DB4-PDB12 si-NPs 2.4.1. Cell uptake and endosomal escape of binary and ternary si-NPs by confocal microscopy Cell uptake and endosomal escape of ternary si-NPs were imaged by confocal microscopy. MDA-MB-231 cells were seeded in 8-well chamber slides (Lab-Tek II Chambered Coverglass, Thermofisher) at a density of 20,000 cells/well and allowed to adhere overnight. Alexa488-labeled ternary si-NPs were added to each well to give a final nucleic acid concentration of 25 (LF2K) or 100 (PDB, DB4-PDB12) nM and incubated with cells in full serum media (DMEM, 10% FBS, 50 μg/mL gentamicin) for 24 h. After 24 h, treatment media was removed, cells were washed once with PBS (−/−), and imaged in PBS (−/−) containing DAPI nuclear stain. For visualizing endosomal escape after 24 h, cells were washed once with PBS (−/−) and incubated in PBS (−/−) containing DAPI nuclear stain and Lysotracker Red (75 nM) at 37°C. Cells were imaged after 1 h incubation with Lysotracker Red. All images were processed using imageJ, and colocalization was analyzed using Just Another Colocalization Plugin (JACoP) [41] . Using JACoP, Mander's overlap coefficients were calculated to represent the fraction of green signal (Alexa488-dsDNA) overlapping with red signal (LysoTracker Red) to quantify colocalization (n ≥ 4 images).
Binary and ternary si-NP stability against heparin-saline disassembly
PDB and DB4-PDB12 si-NPs were loaded with Förster Resonance Energy Transfer (FRET, using Alexa Fluor 488 and Alexa Fluor 546) pair-labeled dsDNAs. Fluorescence intensity was measured using a microplate reader (Tecan Infinite F500, Männedorf, Switzerland) with an excitation wavelength of 488 ± 5 nm. Alexa Fluor 488 emission was collected at 519 ± 5 nm, and Alexa Fluor 546 emission was obtained at 573 ± 5 nm. FRET was calculated as a ratio of the fluorescent intensity as follows:
The stability of PDB and DB4-PDB12 si-NPs was measured in the presence of 2 to 100 U/mL of heparin sodium salt in DPBS [23] . The fluorescence emission at both wavelengths was measured over time following addition of heparin sodium salt. The EC 50 
Ethics statement
The animal studies were conducted with adherence to the guidelines for the care and use of laboratory animals of the National Institutes of Health (NIH). Mice were fed a standard chow diet ad libitum and had free access to water. All protocols were approved by the Institutional Animal Care and Use Committee of Vanderbilt University and done in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Hemolysis assays were done on blood samples taken under a protocol approved by the Vanderbilt Institutional Review Board (IRB).
Results and discussion
3.1. Synthesis and multiparametric screen of ternary si-NPs
Polymer synthesis and characterization
Two core-forming polymers, pDMAEMA (D; M n = 21 kDa and PI = 1.02) and p(DMAEMA-co-BMA) (DB; M n = 18 kDa and PI = 1.05), and two corona-forming diblock polymers, PEG-bpDMAEMA (PD; M n = 22 kDa and PI = 1.16) and PEG-b-p(BMA-co-DMAEMA) (PDB; M n = 23 kDa and PI = 1.03), were synthesized using RAFT polymerization to achieve polymers with low polydispersity and controlled monomer composition and molecular weight (Fig. 1a , Table 1 , and Supplemental Figs. S2 and S3). RAFT polymerization is advantageous for synthesizing biomacromolecules of complex architectures with precision and low polydispersity [42, 43] . Moreover, the simple and single-step polymerizations used herein are scalable and yield polymers which can be rapidly purified.
The well-defined D, DB, PD, and PDB polymers served as the base units of thirty ternary si-NPs formed by varying polymer to siRNA charge ratios (N + :P − ) and the ratio of core:corona polymers within each ternary si-NP class (DB-PD, DB-PDB, and D-PDB) (Fig. 1b-e) . The D-PD combination [44] was not extensively pursued because of its lack of a hydrophobic component. Instead, we focused on "hydrophobized" ternary si-NPs which we hypothesized would outperform purely cationic ternary polyplexes based on our previous findings that balancing cationic and hydrophobic content of binary polyplexes increases stability, endosomolysis, and bioactivity [23, 24] . Importantly, a two-step mixing protocol was adapted from previous reports that show the initial complexing with a cationic component followed by "post-PEGylation" with a diblock, corona-forming polymer improves siRNA packaging over binary complexes with a covalently attached PEG block [44] [45] [46] . The three sub-classes are characterized primarily by the placement of the hydrophobic BMA monomer into either the core-(DB-PD), corona-(D-PDB), or both core-and corona-forming polymers (DB-PDB, Fig. 1b) . Within each sub-class, the amount of non-PEGylated, core-forming polymer was varied (Fig. 1c) to form si-NP precursors (pre-NPs, Supplementary Fig. S4 ). The amount of PEGylated, coronaforming polymer was also varied to generate different degrees of surface PEGylation and ratio of core:corona polymers within each sub-class (Fig. 1d) .
Physicochemical characterization of ternary siRNA-loaded si-NPs
The physicochemical properties of si-NPs from each class were screened, including hydrodynamic diameter, polydispersity, and sur- [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] face charge (zeta potential) at 0 h and 24 h post-fabrication. DB-PD, DB-PDB, and D-PDB ternary si-NPs each formed stable and compact si-NPs (~100-300 nm) (Fig. 2 , Supplemental Table S2 ). While D2-PDB4 and D2-PDB6 si-NPs significantly increased in size over 24 h, all other siNPs retained their initial size. All si-NPs had approximately neutral surface charge which is ideal for systemic administration, with zeta potentials for each si-NP ranging from −1 to +2 mV. Ternary si-NPs utilizing the corona-forming polymer PDB (DB-PDB and D-PDB) displayed PDIs < 0.3, as compared to highly variable PDIs (0.1-1.0) seen in the PD-coated si-NPs (Fig. 2 , Supplemental Table S2 ). In addition, the non-PEGylated, pre-NPs (DB4) rapidly aggregate, forming large and extremely polydisperse structures ( Supplementary Fig. S5 ) at neutral pH (7.4). By contrast, PDB coating of DB4 to form ternary si-NPs gives nanoparticles in the same size range as the binary, parent PDB siNPs (~120 nm; Supplementary Fig. S5 ). Moreover, PDB polymer not loaded with nucleic acid exists as very small micelles at pH 7.4 ( Supplementary Fig. S5 ). In DLS spectra of DB4-PDB12 si-NPs, neither aggregates of the uncoated DB4 pre-NPs or small micelles of the empty PDB micelles appear, suggesting that PDB (when added to pre-NPs in a solution of pH 4) associates with the DB4 pre-NPs and successfully coats the pre-NPs, producing stabilized ternary nanoparticles. In sum, the initial physicochemical screening of this library of ternary si-NPs highlighted the promise of a subgroup of formulations (DB-PDB and D-PDB), which leveraged the PDB polymer as a corona-forming component. These two classes yielded stable si-NPs~100 nm in diameter, with neutral surface charge and low polydispersity.
Characterization of pH-dependent membrane disruption
Entrapment in the endolysosomal pathway and subsequent degradation or trafficking out of the cell limit the effectiveness of many biologic drugs including siRNA [47] [48] [49] . Here, the pH-dependent hemolysis assay was used as a measure of active (non-proton sponge) endolysosomal escape capacity of the different ternary si-NP formulations [50] . The composition of the corona-forming polymer profoundly influenced si-NP hemolysis. PDB-containing si-NPs harbored "switchlike" endosomolytic behavior that is turned on at endosomal pH (6.8 and below) but not extracellular pH (7.4) (Fig. 3) . In contrast, PDcontaining si-NPs showed weak hemolysis and were also hemolytic at pH 7.4, which is indicative of the potential for cytotoxicity (Fig. 3a) . For DB-PDB and D-PDB formulations, hemolysis increased proportionally with increasing amounts of the endosomolytic PDB, coronaforming polymer (Fig. 3b, c) . Therefore, ternary polyplexes which contained PDB as the corona-forming polymer exhibited optimal pHdependent membrane disruptive behavior while PD-corona ternary polyplexes exhibited sporadic hemolysis and in some cases showed hemolysis at pH 7.4, which is generally correlated with cytotoxicity.
In vitro cytocompatibility and cellular uptake of ternary si-NPs
The relative cell uptake of all ternary si-NPs was initially screened in MDA-MB-231 (human triple negative breast cancer) and NIH3T3 (murine embryonic fibroblasts) cells, and cytocompatibility was assessed in MDA-MB-231 and NIH3T3 cells lentivirally-transduced to constitutively express luciferase (L231 and L3T3, respectively). Treatment of L231s for 24 h with all ternary si-NP formulations was well tolerated, although DB-PD si-NPs trended toward increased cytotoxicity as amount of PD polymer was increased (Fig. 4a) . Incubation of L3T3s for 24 h with DB-PD si-NPs loaded with scrambled siRNA exhibited increasing cytotoxicity proportional to the amount of polymer (Fig. 4b) . This is consistent with the observed hemolytic membrane disruption at pH 7.4 for DB-PD polyplexes. DB-PDB or D-PDB si-NPs were not significantly toxic in L3T3s, consistent with observations that they did not cause membrane disruption at pH 7.4 in hemolysis assays (Fig. 4a-b) . Finally, DB2 and DB4 pre-NPs are toxic to the L3T3 cells (~40% and~80% toxicity, respectively) until being coated by the PEGylated, corona-forming PDB polymer (Supplementary Fig. S6 ). Upon coating, cytotoxicity of the DB pre-NPs is entirely mitigated, further suggesting their successful coating and surface presentation of the biocompatible PEG molecules (Supplementary Fig. S6 ). These results underscore the potential cytotoxicity of hemolytic materials which are not well-stabilized (such as DB-PD) and agree with previous reports of cell-type dependent cytotoxicity of nanomaterials [38, 51, 52] .
Next, ternary Alexa488-labeled si-NPs were used to track cell uptake of si-NPs by MDA-MB-231 and NIH3T3 cells. Cellular uptake was dependent upon the chemistry of the cationic block of the coronaforming ternary polymer as well as the ratio of the PEGylated, ternary and the core-forming, binary cationic polymers. Although cells treated with DB-PD ternary si-NPs exhibited nearly 10-fold higher mean fluorescence intensity than DB-PDB and D-PDB si-NPs (Fig. 5) , the total fraction of the cellular population positive for uptake of fluorescent nucleic acid cargo approached 100% for all ternary si-NPs tested. 
T.A. Werfel et al.
Journal of Controlled Release 255 (2017) 12-26
Further, cells treated with the D-PDB and DB-PDB ternary si-NP formulations displayed 5-fold higher mean fluorescence intensity than cells treated with the parental PDB binary si-NPs ( Supplementary Fig.  S7 ). Decreasing cellular si-NP uptake was observed with increasing degree of PEGylation in both cell types. After reaching an~8:1 final N + :P − ratio, each subsequent addition of more corona-forming PEGylated polymer generally decreased cell uptake (Fig. 5) . Importantly, being able to control the amount of corona-forming polymer and thereby the density of PEGylation affords the ability to choose an optimal PEGylation state which provides colloidal stability and also a high level of cell uptake. Figs. S8 and S9) . The DB-PDB group of ternary si-NPs (DB4-PDB6 -DB4-PDB20) achieved 65-85% reduction in luciferase activity at 48 h post-treatment (Supplemental Figs. S8 and S9) , which was greatest of all si-NP classes within our screen. Thus, despite their lower levels of cellular uptake, si-NPs from the DB-PDB are less toxic to cells at physiological pH, exhibit superior potential to escape endolysosomal compartments, and achieve more efficient target gene silencing in treated cells.
Multiparametric evaluation of combinatorial library of ternary siNPs
The panel of siRNA formulations was developed based on the idea that si-NPs that concomitantly overcome multiple siRNA delivery barriers will perform best in in vivo models of disease. By integrating 
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Journal of Controlled Release 255 (2017) [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] data regarding size, zeta potential, cytotoxicity, uptake, pH-dependent hemolysis, and target gene silencing for each si-NP formulation in our library, we were able to generate a heatmap to visualize the performance of each si-NP across a number of assays simultaneously [29] (Fig. 6a) . Importantly, ternary si-NPs that perform well across multiple screening assays achieve the greatest level of gene silencing in vitro (Fig. 6a) . The ternary si-NP surface PEG density (calculated as described in Supplemental Fig. S10 ), cell uptake, and incorporation of the coreforming polymer DB were assessed more closely for correlation to knockdown activity. Within each class of ternary si-NPs, cell uptake was inversely proportional to the surface PEG density (Fig. 6b) . Although cell uptake was necessary for achieving knockdown, it was not sufficient, as many si-NPs with nearly 100% cellular uptake did not exhibit any knockdown (Fig. 6c) . Interestingly, the inclusion of the DB core was a key factor in achieving effective knockdown; nearly all DBcontaining compounds produced target gene reduction, while all si-NPs without the DB core failed to knock down the target gene (Fig. 6d) . The model gene silencing results were confirmed using murine fibroblast (NIH3T3), murine mesenchymal stem cell (MSC), and human breast cancer (MDA-MB-231) cell lines, each with stable luciferase expression. Two lead candidates from each ternary si-NP class were screened for target (luciferase) gene silencing, revealing that cells treated with the DB-PDB class si-NPs achieved greater gene silencing (> 80% protein level knockdown) as compared to analogous si-NPs loaded with scrambled siRNA or other classes of siLuc si-NPs (Fig. 6e-g ). Dose response analysis for MDA-MB-231 cells revealed an IC 50 silencing value of 15.4 nM for DB4-PDB12 ternary si-NPs (Fig. 6h) .
A crux in the development of translatable siRNA therapies is the design of delivery systems which are stable in circulation and divert siRNA from clearance organs (liver, spleen, and kidneys) in order to consequently improve distribution to pathological sites. Effective nanocarriers will overcome systemic pharmacokinetic barriers, in addition to classical subcellular endolysosomal pathway barriers, in order to increase siRNA bioavailability within target cells. Previous combinatorial screens have yielded potent siRNA transfection reagents, but have focused primarily on in vitro and hepatic gene silencing [9, 25, 29, 30, 34, 53] . Alternatively, we envisioned the design of a combinatorial library with parallel aims of increasing in vitro potency (dictated largely by intracellular barriers) and preserving physicochemical characteristics that reduce clearance by organs such as the kidneys, liver, and spleen for better in vivo delivery to alternate sites (e.g., to tumors). With a set of comprehensive cell-and system-level barriers in 
Journal of Controlled Release 255 (2017) [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] mind, a multiparametric in vitro screening approach was conducted on this small library of rationally-designed nanocarriers. The initial physicochemical screening of this library of ternary si-NPs identified a subgroup (DB-PDB and D-PDB) of promising formulations for systemic administration, with appropriate size (~100 nm), zeta potential (~0 mV), and long-term colloidal stability in salts. Ternary si-NP cytotoxicity, cell uptake, and hemolysis assays subsequently revealed formulations (DB4-PDB6 -20) which were ideally tuned for low toxicity and high potential to overcome siRNA delivery barriers. Importantly, these leading formulations achieved the highest gene silencing, and incorporation of the balanced cationic and hydrophobic DB core-component was identified as a crucial parameter for achieving potent RNAi in vitro. For further testing, we down-selected to the leading in vitro formulation, DB4-PDB12, and conducted analysis of biodistribution, pharmacokinetics, and pharmacodynamics compared to our previous gold standard formulation, PDB. New techniques are still desperately needed to enable high-throughput in vivo screening of the pharmacokinetics and biodistribution of siRNA polyplex libraries generated within this study and others. Toward this end, Dahlman et al. recently developed an approach based on barcoded nanoparticles which enable the simultaneous tracking of the biodistribution of up to 30 formulations within a single mouse [54] . In addition to in vivo screening, it is critical to continue developing high throughput, in vitro characterization approaches that can better identify candidate formulations that will optimally deliver siRNA into solid tumors.
3.2.
Comparative analysis of ternary and binary si-NPs in vitro and in vivo 3.2.1. DB4-PDB12 lead ternary si-NPs increase internalization and cytosolic dose of siRNA in vitro The lead ternary si-NP, DB4-PDB12, was selected for further analysis in vitro and in vivo, benchmarking against the parental PDB binary si-NPs [23] . The DB4-PDB12 ternary si-NPs were 124.4 nm in diameter (Fig. 7a) with approximately neutral surface charge Table S2 ), had nearly 4-fold higher cell uptake than the parental PDB binary si-NPs, and decreased colocalization of nucleic acid cargo with endolysosomes (labeled with LysoTracker Red) by 8.7-and 2.5-fold compared to Lipofectamine 2000 (LF2K) and PDB si-NPs, respectively (Fig. 7b-e and Supplemental Figs. S11 and S12). Increased cytosolic delivery of nucleic acid cargo from DB4-PDB12 si-NPs through the endolysosomal pathway was also visualized by confocal microscopy of cells treated with fluorescently-tagged si-NPs and co-stained with Lysotracker Red (Fig. 7e and Supplemental Fig.  S12) . Thus, the ternary analog, DB4-PDB12, maintained the important physicochemical characteristics of PDB for systemic administration (size and surface charge) while increasing lipid bilayer translocation (cell uptake and endosomal escape) of the siRNA delivery system.
Pharmacokinetics, biodistribution, and bioactivity of binary PDB and ternary DB4-PDB12 si-NPs
To assess the stability of si-NPs in an assay that models the microenvironment of the kidney GBM, we measured binary PDB and ternary DB4-PDB12 si-NP stability in the presence of heparan sulfate. Using a FRET-based readout, DB4-PDB12 si-NPs were significantly more resistant to heparin-mediated disassembly over time when compared to PDB binary si-NPs (Fig. 8a and Supplemental Figs. S13 and S14). Consistent with these results, the fluorescently-labeled cargo of DB4-PDB12 ternary si-NPs exhibited lower concentration in the kidneys of athymic female tumor-bearing mice relative to PDB binary si-NPs following i.v. injection ( Fig. 8b and Supplementary Fig. S15 ), suggesting that the ternary si-NPs have decreased susceptibility to GBM-triggered disassembly and renal clearance in vivo. In agreement with better stability within the circulation, DB4-PDB12 ternary si-NPs had a 1.6-fold greater area under the curve (AUC) value compared to PDB binary si-NPs (Fig. 8c) . Greater stability and bioavailability of DB4-PDB12 ternary si-NPs also correlated to a 2.6-fold increase in accumulation within orthotopic MDA-MB-231 breast tumor xenografts following i.v. injection relative to PDB binary si-NPs (Fig. 8d and Supplementary Figs. S15 and 16). The correlation between higher circulation time and greater tumor biodistribution is consistent with the principles of enhanced permeability and retention(EPR)-based tumor accumulation [55, 56] . In total, DB4-PDB12 si-NPs showed increased blood plasma AUC, reduced kidney accumulation, and increased tumor accumulation when compared to our previously optimized PDB binary si-NP composition [23] , all advantageous characteristics for effective systemic delivery of siRNA to solid tumors.
The siRNA silencing efficacy of lead DB4-PDB12 ternary si-NPs was evaluated in vivo in orthotopic L231 (MDA-MB-231 triple negative breast cancer cells constitutively expressing luciferase) tumors. DB4-PDB12 ternary si-NPs or PDB binary si-NPs loaded with siLuc siRNAs were injected i.v. in two doses, (days 17 and 18 after tumor inoculation), and tumor luciferase expression was assessed using intravital bioluminescence. As early as 24 h after treatment, luciferase was diminished by~45% in tumors of mice treated with siLuc-loaded DB4-PDB12 si-NPs as compared to siScrambled control si-NPs (p = 0.01). Increased silencing by the DB4-PDB12 si-NPs was detected at 48 h and 72 h after treatment, with~51% (p < 0.01) and~59% (p < 0.01) luciferase attenuation, respectively (Fig. 8e) . Moreover, DB4-PDB12 ternary siLuc-NPs decreased luciferase signal significantly more than PDB binary siLuc-NPs at 24, 48, and 72 h (45% vs. -23%, 51% vs. 20%, and 59% vs. 42% reduction, respectively; Fig. 8e ) when compared head-to-head.
Recent studies have identified the kidneys as the major route for in vivo clearance of i.v.-injected siRNA polyplexes assembled by electrostatic interactions [21, 22] . In these studies, anionic proteoglycans such as heparan sulfates of the GBM were identified as culprits for polyplex disassembly and clearance through the kidneys/urine. Therefore, it is functionally significant that the DB4-PDB12 ternary si-NPs resist heparin-mediated disassembly, reduce clearance through the kidneys, and consequently achieve higher AUCs after i.v. administration when benchmarked against PDB binary si-NPs which previously were optimized to outperform PD (100% cationic) si-NPs [23] . Importantly, the optimized DB4-PDB12 formulation only accumulated~50% within the kidneys (Supplementary Fig. S14b ), whereas siRNA polyplexes reported in the literature typically show > 75% renal accumulation [11, 19, 20, 28, 46, [57] [58] [59] , severely attenuating the amount of injected dose available for delivery to non-renal target organs. The increased AUC of DB4-PDB12 ternary si-NPs also correlated to higher siRNA delivery to orthotopic breast tumors in our studies. Although recent studies highlight the variability of the EPR effect [60, 61] , Clark et al. recently observed EPR-based tumor accumulation of CRLX101 in gastrointestinal adeno-or squamous cell carcinomas in human patients while the nanomedicine was absent in surrounding, non-neoplastic tissue [62] . Generally, it is accepted that EPR-based accumulation of nanoparticles within tumors occurs when particles fall within the appropriate size range and correlates with circulation AUC as observed within the current study [55, 56] . In addition to passive targeting by the EPR effect, active targeting through receptor-ligand interactions (e.g., transferrin, folic acid, RGD, HER2-ScFv) is a popular approach for increasing tumor retention after i.v. administration of si-NPs, but active targeting is inherently limited if the nanocarrier is rapidly cleared. For this reason, we focused on initially improving the pharmacokinetics of our ternary si-NPs through modulation of the si-NP core chemistry, and it is anticipated that inclusion of active targeting will further improve our lead si-NPs in the future.
Conclusions
Many siRNA transfection reagents have been primarily optimized to achieve gene silencing in vitro, and therefore, utilize design principles (e.g., extreme cationic charge for cell internalization [14] ) which do not translate well to in vivo settings, especially for delivery to non-hepatic targets. Due to the shortcomings of strictly cationic polyplexes (such as colloidal instability and short persistence in circulation in vivo), we combinatorially incorporated hydrophobicity into the core, corona, and both core and corona of a rationally-designed library of 30 distinct ternary architecture si-NPs to stabilize them through both electrostatic and van der Waals forces. Within each class, the amount of coreforming polymer, corona-forming polymer, and the ratio of the two were varied in order to systematically study the effects of each component as well as investigate structure-function relationships. The full library was screened by a multiparametric strategy which facilitated identification of a lead candidate that is optimized to overcome both cell-level (e.g., lipid bilayer translocation) and systemic (e.g., stability in blood and rapid renal clearance) delivery barriers. Our lead candidate from this screen, DB4-PDB12, is small (~100 nm), stable in size, efficiently internalized by cells, potently endosomolytic, and effective at gene silencing in vitro. DB4-PDB12 si-NPs were benchmarked against our previous "gold-standard" PDB si-NPs [23] and exhibited superior cell internalization and cytosolic delivery of nucleic acid cargo, increased resilience to heparan sulfate-mediated disassembly, reduced renal clearance, increased blood circulation AUC, and improved target gene silencing within tumors after intravenous delivery. These results confirmed that a multiparametric screening approach identified new lead formulations within the PEGylated polyplex class of siRNA carriers. New insights were also gleaned regarding the value of ternary over binary formulations, tuning of PEG density, and comprehensive incorporation of balanced cationic and hydrophobic content within both core-and corona-forming polyplex components.
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